The global prevalence of reported penicillin allergy: A systematic review and meta-analysis

Akish Luintel1, Joseph Healy2, Michael Blank2

  • 1Institute of Global Health Innovation, Imperial College London, UK.

The Journal of Infection
|January 28, 2025
PubMed
Abstract

Insights

Globally, 9.4% of adults are labeled with penicillin allergy (PenA), a condition often misdiagnosed. This prevalence varies significantly by country income, highlighting the need for broader data collection to support penicillin de-labeling initiatives.

Area of Science:

  • Clinical Medicine
  • Infectious Diseases
  • Public Health

Background:

  • Penicillin allergy (PenA) labels lead to broad-spectrum antibiotic use, increasing antimicrobial resistance and adverse outcomes.
  • Approximately 95% of patients with a PenA label are likely misdiagnosed.
  • Penicillin de-labeling programs are emerging but are currently limited in scope.

Purpose of the Study:

  • To determine the global prevalence of penicillin allergy (PenA) labels.
  • To inform the potential impact and scope of penicillin de-labeling programs worldwide.

Main Methods:

  • Systematic review and meta-analysis of adult PenA prevalence studies.
  • Inclusion criteria: studies published between January 2003 and June 2023.
  • Data extracted: PenA prevalence, allergy recording methods, healthcare setting, country income.

Main Results:

  • 174 studies from 28 countries were analyzed, encompassing 18,352 patients.
  • Global PenA prevalence was 9.4% (95% CI 8.4-10.4%).
  • High-income countries (HICs) reported higher PenA prevalence (9.9%) compared to middle-income countries (MICs) (4.4%).
  • Studies were heavily skewed towards HICs (92%) and secondary care settings.
  • Allergy recording methods significantly impacted reported prevalence.

Conclusions:

  • PenA prevalence data is concentrated in HICs and secondary care, with limited representation from Africa, Asia, and South America.
  • There is a critical need for expanded epidemiological research in under-represented global regions.
  • Addressing data gaps is essential for effective global penicillin de-labeling strategies.

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
27.2K
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
806
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
770
Cross-reactivity00:42

Cross-reactivity

Overview
30.9K
Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
491